Vaccines and disease-modifying treatments

Mult Scler Relat Disord. 2018 Nov:26:A1-A2. doi: 10.1016/j.msard.2018.10.017. Epub 2018 Oct 24.
No abstract available

Keywords: Alemtuzumab; B cell depleting agents; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder; Ocrelizumab; Vaccines.

Publication types

  • Editorial

MeSH terms

  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunotherapy*
  • Multiple Sclerosis / prevention & control*
  • Multiple Sclerosis / therapy*
  • Vaccines / therapeutic use*

Substances

  • Immunologic Factors
  • Vaccines